Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study

Table 1

Different chemotherapy regimens of all patients.

Chemotherapy regimen	Patients (number)
ECF (epirubicin, cisplatin, and 5-fluorouracil)	16
DOX (docetaxel, oxaliplatin, and capecitabine)	46
EOX (capecitabine, oxaliplatin, and ED epirubicin)	7
DCF (docetaxel, cisplatin, and 5-fluorouracil)	2
2ECF + 4DCF	1
CDDP(cisplatin) + capecitabine	1
FOLFOX (folic acid, fluorouracil, and oxaliplatin)	9
1 DOX + 3 DOF (docetaxel, oxaliplatin, and fluorouracil)	1
EOF (epirubicin, oxaliplatin, and 5-fluorouracil)	3